Pre-clinical Assessment of the Absorption, Distribution, Metabolism, and Excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an Orally Bioavailable Systemic Hedgehog Signaling Pathway Inhibitor

Hoi Shan Wong, Jacob Chen, Bilin Chou, Jason Halladay, Jane Kenny, Hank La, James Marsters Jr, Emile Plise, Patrick Rudewicz, Kirk Robarge, Young Shin, Susan Wong, Chi Zhang, S Cyrus Khojasteh
November 1, 2009
Learn More LinkedIn Twitter Facebook Email